{"pmid":32462841,"title":"[Obesity and risk of severe COVID-19].","text":["[Obesity and risk of severe COVID-19].","Obesity represents a higher risk of severe COVID-19 infection, which may lead to the requirement of a mechanical ventilation in intensive care units and premature death. The underlying mechanisms are multiple: alteration of the respiratory performance, presence of comorbidities such as diabetes, hypertension or obstructive sleep apnea, finally inadequate and excessive immunological responses, possibly aggravated by ectopic intrathoracic fat depots. Thus, COVID-19 may challenge the so-called << obesity paradox >> commonly reported by intensivists in patients with acute respiratory distress syndrome. These findings require reinforced preventive and curative measures among obese patients to limit the risk of progression towards an unfavorable outcome in case of COVID-19.","Rev Med Suisse","Scheen, Andre J","32462841"],"abstract":["Obesity represents a higher risk of severe COVID-19 infection, which may lead to the requirement of a mechanical ventilation in intensive care units and premature death. The underlying mechanisms are multiple: alteration of the respiratory performance, presence of comorbidities such as diabetes, hypertension or obstructive sleep apnea, finally inadequate and excessive immunological responses, possibly aggravated by ectopic intrathoracic fat depots. Thus, COVID-19 may challenge the so-called << obesity paradox >> commonly reported by intensivists in patients with acute respiratory distress syndrome. These findings require reinforced preventive and curative measures among obese patients to limit the risk of progression towards an unfavorable outcome in case of COVID-19."],"journal":"Rev Med Suisse","authors":["Scheen, Andre J"],"date":"2020-05-29T11:00:00Z","year":2020,"_id":"32462841","source":"PubMed","week":"202022|May 25 - May 31","locations":["obese"],"topics":["Treatment","Mechanism"],"weight":1,"_version_":1668079521509670912,"score":9.490897,"similar":[{"pmid":32422280,"title":"Two important controversial risk factors in SARS-CoV-2 infection: Obesity and smoking.","text":["Two important controversial risk factors in SARS-CoV-2 infection: Obesity and smoking.","The effects of obesity and smoking in the coronavirus disease 2019 (COVID-19) pandemic remain controversial. Angiotensin converting enzyme 2 (ACE2), a component of the renin-angiotensin system (RAS), is the human cell receptor of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of COVID-19. ACE2 expression increases on lung alveolar epithelial cells and adipose tissue due to obesity, smoking and air pollution. A significant relationship exists between air pollution and SARS-CoV-2 infection, as more severe COVID-19 symptoms occur in smokers; comorbid conditions due to obesity or excess ectopic fat accumulation as underlying risk factors for severe COVID-19 strongly encourage the virus/ACE2 receptor-ligand interaction concept. Indeed, obesity, air pollution and smoking associated risk factors share underlying pathophysiologies that are related to the Renin-Angiotensin-System in SARS-CoV-2 infection. The aim of this review is to emphasize the mechanism of receptor-ligand interaction and its impact on the enhanced risk of death due to SARS-CoV-2 infection.","Environ Toxicol Pharmacol","Engin, Ayse Basak","Engin, Evren Doruk","Engin, Atilla","32422280"],"abstract":["The effects of obesity and smoking in the coronavirus disease 2019 (COVID-19) pandemic remain controversial. Angiotensin converting enzyme 2 (ACE2), a component of the renin-angiotensin system (RAS), is the human cell receptor of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of COVID-19. ACE2 expression increases on lung alveolar epithelial cells and adipose tissue due to obesity, smoking and air pollution. A significant relationship exists between air pollution and SARS-CoV-2 infection, as more severe COVID-19 symptoms occur in smokers; comorbid conditions due to obesity or excess ectopic fat accumulation as underlying risk factors for severe COVID-19 strongly encourage the virus/ACE2 receptor-ligand interaction concept. Indeed, obesity, air pollution and smoking associated risk factors share underlying pathophysiologies that are related to the Renin-Angiotensin-System in SARS-CoV-2 infection. The aim of this review is to emphasize the mechanism of receptor-ligand interaction and its impact on the enhanced risk of death due to SARS-CoV-2 infection."],"journal":"Environ Toxicol Pharmacol","authors":["Engin, Ayse Basak","Engin, Evren Doruk","Engin, Atilla"],"date":"2020-05-19T11:00:00Z","year":2020,"_id":"32422280","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1016/j.etap.2020.103411","keywords":["air pollution","angiotensin ii","angiotensin-converting-enzyme inhibitors","covid-19","obesity","smoking"],"topics":["Mechanism","Treatment"],"weight":1,"_version_":1667254896722706432,"score":193.49573},{"pmid":32447101,"title":"Prognostic factors in patients with diabetes hospitalized for COVID-19: Findings from the CORONADO study and other recent reports.","text":["Prognostic factors in patients with diabetes hospitalized for COVID-19: Findings from the CORONADO study and other recent reports.","Diabetes mellitus is challenging in the context of the COVID-19 pandemic. The prevalence of diabetes patients hospitalized in intensive care units for COVID-19 is two- to threefold higher, and the mortality rate at least double, than that of non-diabetes patients. As the population with diabetes is highly heterogeneous, it is of major interest to determine the risk factors of progression to a more serious life-threatening COVID-19 infection. This brief review discusses the main findings of CORONADO, a prospective observational study in France that specifically addressed this issue as well as related observations from other countries, mainly China and the US. Some prognostic factors beyond old age have been identified: for example, an increased body mass index is a major risk factor for requiring respiratory assistance. Indeed, obesity combines several risk factors, including impaired respiratory mechanics, the presence of other comorbidities and inappropriate inflammatory responses, partly due to ectopic fat deposits. While previous diabetic microvascular (renal) and macrovascular complications also increase risk of death, the quality of past glucose control had no independent influence on hospitalized diabetes patient outcomes, and whether the quality of glucose control might modulate risk of COVID-19 in non-hospitalized diabetes patients is still unknown. In addition, no negative signs regarding the use of RAAS blockers and DPP-4 inhibitors and outcomes of COVID-19 could be identified. Hyperglycaemia at the time of hospital admission is associated with poor outcomes, but it may simply be considered a marker of severity of the infection. Thus, the impact of glucose control during hospitalization on outcomes related to COVID-19, which was not investigated in the CORONADO study, is certainly deserving of specific investigation.","Diabetes Metab","Scheen, Andre J","Marre, Michel","Thivolet, Charles","32447101"],"abstract":["Diabetes mellitus is challenging in the context of the COVID-19 pandemic. The prevalence of diabetes patients hospitalized in intensive care units for COVID-19 is two- to threefold higher, and the mortality rate at least double, than that of non-diabetes patients. As the population with diabetes is highly heterogeneous, it is of major interest to determine the risk factors of progression to a more serious life-threatening COVID-19 infection. This brief review discusses the main findings of CORONADO, a prospective observational study in France that specifically addressed this issue as well as related observations from other countries, mainly China and the US. Some prognostic factors beyond old age have been identified: for example, an increased body mass index is a major risk factor for requiring respiratory assistance. Indeed, obesity combines several risk factors, including impaired respiratory mechanics, the presence of other comorbidities and inappropriate inflammatory responses, partly due to ectopic fat deposits. While previous diabetic microvascular (renal) and macrovascular complications also increase risk of death, the quality of past glucose control had no independent influence on hospitalized diabetes patient outcomes, and whether the quality of glucose control might modulate risk of COVID-19 in non-hospitalized diabetes patients is still unknown. In addition, no negative signs regarding the use of RAAS blockers and DPP-4 inhibitors and outcomes of COVID-19 could be identified. Hyperglycaemia at the time of hospital admission is associated with poor outcomes, but it may simply be considered a marker of severity of the infection. Thus, the impact of glucose control during hospitalization on outcomes related to COVID-19, which was not investigated in the CORONADO study, is certainly deserving of specific investigation."],"journal":"Diabetes Metab","authors":["Scheen, Andre J","Marre, Michel","Thivolet, Charles"],"date":"2020-05-25T11:00:00Z","year":2020,"_id":"32447101","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1016/j.diabet.2020.05.008","keywords":["diabetic complications","glucose control","mechanical ventilation","mortality","obesity","sars-cov-2"],"locations":["France","China","US"],"countries":["France","United States","China"],"countries_codes":["FRA|France","USA|United States","CHN|China"],"topics":["Treatment","Diagnosis"],"weight":1,"_version_":1667698385913643010,"score":159.55913},{"pmid":32472662,"title":"COVID-19 and diabetes: Is there enough evidence?","text":["COVID-19 and diabetes: Is there enough evidence?","The pandemic of COVID-19, a disease caused by a novel coronavirus SARS-CoV-2, is associated with significant morbidity and mortality. Recent data showed that hypertension, diabetes mellitus, cardiovascular diseases, and chronic obstructive pulmonary disease were the most prevalent comorbidities in COVID-19 patients. Additionally, data indicate that hypertension, diabetes, and cardiovascular diseases are important risk factors for progression and unfavorable outcome in COVID-19 patients. There is only limited amount of data regarding follow-up of these patients, and they provided conflicting results. The main limitation is a small number of participants and particularly those who experienced primary composite outcome (admission in intensive care unit, use of mechanical ventilation, or death). Additionally, the limited number of patients was essential obstacle for performing analysis that would include many confounding factors such as advanced age, smoking status, and obesity and potentially change conclusion. So far, there is no study that demonstrated independent predictive value of diabetes on mortality in COVID-19 patients, but there are many speculations about the association between diabetes and susceptibility to novel coronavirus, as well as its impact on progression and prognosis of COVID-19. The aim of this review article was to summarize the current knowledge about the relationship between diabetes and COVID-19 and its role in outcome in these patients.","J Clin Hypertens (Greenwich)","Tadic, Marijana","Cuspidi, Cesare","Sala, Carla","32472662"],"abstract":["The pandemic of COVID-19, a disease caused by a novel coronavirus SARS-CoV-2, is associated with significant morbidity and mortality. Recent data showed that hypertension, diabetes mellitus, cardiovascular diseases, and chronic obstructive pulmonary disease were the most prevalent comorbidities in COVID-19 patients. Additionally, data indicate that hypertension, diabetes, and cardiovascular diseases are important risk factors for progression and unfavorable outcome in COVID-19 patients. There is only limited amount of data regarding follow-up of these patients, and they provided conflicting results. The main limitation is a small number of participants and particularly those who experienced primary composite outcome (admission in intensive care unit, use of mechanical ventilation, or death). Additionally, the limited number of patients was essential obstacle for performing analysis that would include many confounding factors such as advanced age, smoking status, and obesity and potentially change conclusion. So far, there is no study that demonstrated independent predictive value of diabetes on mortality in COVID-19 patients, but there are many speculations about the association between diabetes and susceptibility to novel coronavirus, as well as its impact on progression and prognosis of COVID-19. The aim of this review article was to summarize the current knowledge about the relationship between diabetes and COVID-19 and its role in outcome in these patients."],"journal":"J Clin Hypertens (Greenwich)","authors":["Tadic, Marijana","Cuspidi, Cesare","Sala, Carla"],"date":"2020-05-31T11:00:00Z","year":2020,"_id":"32472662","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1111/jch.13912","keywords":["covid-19","coronavirus","diabetes","outcome","risk factors"],"topics":["Treatment","Mechanism","Diagnosis"],"weight":1,"_version_":1668255193282641920,"score":155.19955},{"pmid":32314503,"title":"Obesity and SARS-CoV-2: a population to safeguard.","text":["Obesity and SARS-CoV-2: a population to safeguard.","Evidence has lately emerged regarding an increased risk of SARS-CoV-2 with worse prognosis in patients with obesity, especially among the young. Weight excess is a well-established respiratory disease risk factor, and the newly reported correlation is therefore unsurprising. The underlying pathophysiology is likely multi-stranded, ranging from complement system hyperactivation, increased Interleukin-6 secretion, chronic inflammation, presence of comorbidities such as diabetes and hypertension, and a possible local, detrimental effect within the lung. Further understanding the link between obesity and SARS-CoV-2 is crucial, as this could aid proper tailoring of immunomodulatory treatments, together with improving stratification among those possibly requiring critical care. This article is protected by copyright. All rights reserved.","Diabetes Metab Res Rev","Watanabe, Mikiko","Risi, Renata","Tuccinardi, Dario","Baquero, Claudia J","Manfrini, Silvia","Gnessi, Lucio","32314503"],"abstract":["Evidence has lately emerged regarding an increased risk of SARS-CoV-2 with worse prognosis in patients with obesity, especially among the young. Weight excess is a well-established respiratory disease risk factor, and the newly reported correlation is therefore unsurprising. The underlying pathophysiology is likely multi-stranded, ranging from complement system hyperactivation, increased Interleukin-6 secretion, chronic inflammation, presence of comorbidities such as diabetes and hypertension, and a possible local, detrimental effect within the lung. Further understanding the link between obesity and SARS-CoV-2 is crucial, as this could aid proper tailoring of immunomodulatory treatments, together with improving stratification among those possibly requiring critical care. This article is protected by copyright. All rights reserved."],"journal":"Diabetes Metab Res Rev","authors":["Watanabe, Mikiko","Risi, Renata","Tuccinardi, Dario","Baquero, Claudia J","Manfrini, Silvia","Gnessi, Lucio"],"date":"2020-04-22T11:00:00Z","year":2020,"_id":"32314503","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.1002/dmrr.3325","topics":["Treatment"],"weight":1,"_version_":1666138493573660673,"score":150.30179},{"pmid":32463545,"title":"Obesity and COVID-19: an Italian snapshot.","text":["Obesity and COVID-19: an Italian snapshot.","OBJECTIVE: The clinical manifestations of COVID-19 run from asymptomatic disease to severe acute respiratory syndrome. Older age and comorbidities are associated to more severe disease. A role of obesity is suspected. METHODS: We enrolled patients hospitalized in the medical COVID-19 ward with SARS-CoV-2 related pneumonia. Primary outcome of the study was to assess the relationship between the severity of COVID-19 and obesity classes according to BMI. RESULTS: 92 patients (61.9% males; age 70.5+/-13.3 years) were enrolled. Patients with overweight and obesity were younger than normal-weight patients (68.0+/-12.6 and 67.0+/-12.6 years vs. 76.1+/-13.0 years, p<0.01). A higher need for assisted ventilation beyond pure oxygen support (Invasive Mechanical Ventilation or Non-Invasive Ventilation) and a higher admission to intensive or semi-intensive care units was observed in patients with overweight and obesity (p<0.01 and p < 0.05, respectively) even after adjusting for sex, age and comorbidities (p<0.05 and p<0.001, respectively), or when patients with dementia or advanced cancer were removed from the analysis (p<0.05). CONCLUSION: Patients with overweight and obesity admitted in a medical ward for SARS-CoV-2 related pneumonia, despite their younger age, required more frequently assisted ventilation and access to intensive or semi-intensive care units than normal weight patients.","Obesity (Silver Spring)","Busetto, Luca","Bettini, Silvia","Fabris, Roberto","Serra, Roberto","Dal Pra', Chiara","Maffei, Pietro","Rossato, Marco","Fioretto, Paola","Vettor, Roberto","32463545"],"abstract":["OBJECTIVE: The clinical manifestations of COVID-19 run from asymptomatic disease to severe acute respiratory syndrome. Older age and comorbidities are associated to more severe disease. A role of obesity is suspected. METHODS: We enrolled patients hospitalized in the medical COVID-19 ward with SARS-CoV-2 related pneumonia. Primary outcome of the study was to assess the relationship between the severity of COVID-19 and obesity classes according to BMI. RESULTS: 92 patients (61.9% males; age 70.5+/-13.3 years) were enrolled. Patients with overweight and obesity were younger than normal-weight patients (68.0+/-12.6 and 67.0+/-12.6 years vs. 76.1+/-13.0 years, p<0.01). A higher need for assisted ventilation beyond pure oxygen support (Invasive Mechanical Ventilation or Non-Invasive Ventilation) and a higher admission to intensive or semi-intensive care units was observed in patients with overweight and obesity (p<0.01 and p < 0.05, respectively) even after adjusting for sex, age and comorbidities (p<0.05 and p<0.001, respectively), or when patients with dementia or advanced cancer were removed from the analysis (p<0.05). CONCLUSION: Patients with overweight and obesity admitted in a medical ward for SARS-CoV-2 related pneumonia, despite their younger age, required more frequently assisted ventilation and access to intensive or semi-intensive care units than normal weight patients."],"journal":"Obesity (Silver Spring)","authors":["Busetto, Luca","Bettini, Silvia","Fabris, Roberto","Serra, Roberto","Dal Pra', Chiara","Maffei, Pietro","Rossato, Marco","Fioretto, Paola","Vettor, Roberto"],"date":"2020-05-29T11:00:00Z","year":2020,"_id":"32463545","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1002/oby.22918","keywords":["covid-19","sars-cov-2","obesity"],"locations":["Italian"],"countries":["Italy"],"countries_codes":["ITA|Italy"],"topics":["Treatment","Diagnosis"],"weight":1,"_version_":1668079521204535298,"score":140.62277}]}